Clinical Guides
Gestational Diabetes Mellitus: Screening, Diagnosis and Care
An India-centred guide to universal glucose testing, treatment escalation, fetal surveillance, delivery planning and lifelong metabolic follow-up after gestational diabetes.
MedNext Academy | 12 min read
Gestational Diabetes Mellitus: Screening, Diagnosis and Care
An India-centred guide to universal glucose testing, treatment escalation, fetal surveillance, delivery planning and lifelong metabolic follow-up after gestational diabetes.
Summary
Gestational diabetes mellitus is hyperglycaemia first recognised during pregnancy that does not meet criteria for overt diabetes. It matters because untreated maternal hyperglycaemia increases fetal overgrowth, birth trauma, hypertensive disease, operative delivery, neonatal hypoglycaemia and later metabolic risk for mother and child. India uses a pragmatic public-health pathway: the NHM technical guideline endorses universal testing with 75 g oral glucose, irrespective of the last meal, and a 2-hour venous plasma glucose threshold of at least 140 mg/dL; test at the first antenatal contact and repeat at 24-28 weeks when the first result is negative. This national operational method differs from fasting international diagnostic strategies, so a clinician must name the protocol used rather than mix thresholds. After diagnosis, explain that GDM is not a personal failure, assess whether overt pre-existing diabetes is possible, begin individualised medical nutrition therapy and safe physical activity, teach glucose monitoring where feasible, and review within a defined interval. Add insulin when targets are not met; the Indian guideline also permits metformin in specified circumstances under clinician supervision. Care includes maternal blood pressure, weight, medication safety, fetal growth and amniotic-fluid surveillance, delivery planning and neonatal readiness. Testing must continue postpartum because glucose often normalises while future type 2 diabetes risk remains high. WHO's 2025 guideline emphasises individualised targets, regular monitoring, medicines when needed and lifelong care. This guide is educational; local obstetric-diabetes protocols govern prescriptions and delivery timing.
How Common Is It?
GDM is one of the most frequent medical complications of pregnancy, but prevalence depends on population risk and the diagnostic protocol. WHO reported in 2025 that diabetes affects more than 21 million pregnancies globally, approximately one in six, encompassing pre-existing diabetes and hyperglycaemia first detected in pregnancy. Indian prevalence is heterogeneous across rural and urban settings, age groups, BMI distributions and testing methods. The NHM technical guideline cites an Indian field experience in which new GDM diagnoses occurred across pregnancy—roughly one third in the first trimester, two fifths in the second and more than one quarter in the third—supporting early universal testing and repeat testing rather than risk-factor-only screening. These proportions are not a national prevalence estimate and should not be presented as one. Ascertainment is affected by whether the woman arrives fasting, completes a glucose load, returns for results and receives repeat testing. India's non-fasting single-step method was chosen partly for feasibility in busy public services where requiring a fasting return can lose patients. A programme should therefore monitor the proportion of eligible pregnancies actually tested at booking and again at 24-28 weeks, invalid samples repeated, positive results linked to treatment, and postpartum tests completed. Rising maternal age, adiposity and type 2 diabetes burden make GDM clinically important, but lean and young women can also develop it. Universal screening prevents false reassurance based on appearance or absent family history.
Risk Factors
Risk factors raise probability but do not replace universal Indian screening. They include previous GDM, prior macrosomic infant, unexplained stillbirth, congenital anomaly or neonatal loss, family history of type 2 diabetes, overweight or obesity, advancing maternal age, polycystic ovary syndrome, physical inactivity, glucocorticoid exposure and current ultrasound evidence of excessive fetal growth or polyhydramnios. A history of impaired glucose tolerance or a previous abnormal postpartum test is particularly important. South Asian ethnicity carries increased metabolic risk at lower BMI, so a 'normal-looking' patient is not exempt. At booking, distinguish risk for GDM from features suggesting overt diabetes: marked hyperglycaemia, classic polyuria and polydipsia, weight loss, ketosis, or a result meeting non-pregnancy diabetes thresholds requires prompt specialist assessment. Once GDM is diagnosed, risk stratification shifts toward treatment failure and complications. Higher glucose values, fasting elevation, early diagnosis, obesity, hypertension, poor access to food choices or monitoring, and inability to attend review may predict the need for more support. Fetal overgrowth, abnormal fluid, hypertension or reduced movements changes obstetric surveillance. Ask about medicines that affect glucose, cultural dietary patterns, food insecurity, work schedule, literacy and ability to use a meter. Avoid blame: placental hormones drive insulin resistance, and stigma reduces engagement. Postpartum risk persists after a normal pregnancy-end test, especially with recurrent GDM, obesity or family history, so the history belongs permanently in the medical record.
Diagnosis
History
Most GDM is asymptomatic. Record gestation, prior test results and the exact protocol used; previous GDM or large infant; family history; PCOS; weight trajectory; medicines; diet, activity and access to testing. Ask for symptoms of overt diabetes, infection, hypertension, reduced fetal movement and preterm labour. Establish whether the glucose sample followed the Indian non-fasting DIPSI-style pathway or a fasting international OGTT because values are not interchangeable.
Examination
Measure blood pressure with correct cuff size, weight and BMI, and assess hydration, infection and signs of vascular or endocrine disease when indicated. Obstetric examination documents fundal height and fetal growth trajectory. Disproportionate growth or excess fluid warrants ultrasound assessment but does not itself diagnose GDM. Severe hyperglycaemia with vomiting, dehydration, tachypnoea or altered sensorium requires emergency metabolic assessment.
Investigations
The NHM national guideline uses 75 g oral glucose irrespective of last meal with venous plasma glucose measured at 2 hours; at least 140 mg/dL diagnoses GDM. Test at first antenatal contact and repeat at 24-28 weeks if negative. If vomiting occurs within 30 minutes, repeat next day; delayed vomiting still requires documented local handling. Do not diagnose from a capillary meter when the protocol specifies a laboratory-quality venous result. Check for overt diabetes according to current specialist criteria when values are marked or detected early. After diagnosis, use fasting and post-meal monitoring as locally prescribed, with HbA1c used selectively—not as a replacement screening test. Evaluate fetal growth and fluid according to control and treatment.
Differential Diagnosis
The first distinction is GDM versus overt diabetes first discovered in pregnancy. Overt diabetes is more likely with diagnostic-range fasting or random values outside pregnancy, pronounced symptoms, ketosis, early marked hyperglycaemia or established microvascular disease and needs a pre-existing-diabetes pathway. Stress hyperglycaemia can occur during acute infection, corticosteroid treatment or severe illness; it requires repeat assessment but cannot be ignored. A spurious result may follow an incorrectly prepared glucose drink, incomplete dose, wrong timing, vomiting, sample handling error or use of a capillary device against protocol. Glycosuria is common in pregnancy and neither confirms nor excludes GDM. HbA1c is affected by altered red-cell turnover and anaemia and is not the stand-alone Indian screening test. When fetal size appears large, consider incorrect gestational dating, constitutional size and measurement error in addition to maternal hyperglycaemia. Polyhydramnios also has fetal anomaly, infection, alloimmunisation and idiopathic causes. Conversely, normal fetal size does not show that maternal glucose is safe. Symptoms attributed to hyperglycaemia—urinary frequency, thirst and fatigue—overlap normal pregnancy, anaemia and urinary infection. Postpartum persistent hyperglycaemia may represent previously unrecognised type 2 diabetes rather than residual GDM. A diagnosis should therefore record protocol, gestation, numerical value, sample type and confirmatory context, preventing later clinicians from treating unlike tests as equivalent.
Management
Give results promptly and organise a structured education visit. Explain maternal and neonatal implications without catastrophising. Initial management is individualised medical nutrition therapy that distributes carbohydrate, protects adequate pregnancy nutrition and fits local foods; avoid severe caloric restriction or ketogenic diets. Encourage safe regular activity, such as walking after meals, when there is no obstetric contraindication. Teach glucose-monitor technique and agree written targets and review timing according to the treating service. Review the glucose log alongside meal timing, symptoms and meter quality. Escalate to pharmacotherapy when values remain above target despite a reasonable lifestyle trial, or immediately when hyperglycaemia is substantial. Insulin has the longest pregnancy safety experience and allows tailored fasting and meal control; NHM permits metformin for selected women after clinical assessment. Monitor blood pressure, weight and complications, and arrange fetal growth and fluid surveillance based on control, medicines and local protocol. Delivery timing and mode are obstetric decisions based on control, fetal growth, maternal disease and previous history, not the GDM label alone. Ensure the neonatal team can monitor feeding and glucose when indicated. During labour, follow institutional glucose and medicine instructions. Stop or adjust pregnancy-specific treatment after birth only under the care plan. Promote early feeding, arrange maternal postpartum glucose testing, document GDM in discharge records and establish lifelong diabetes-prevention follow-up.
Prescribing Information
Insulin regimens should target the patient's actual pattern: basal insulin for fasting elevation and rapid-acting insulin around meals when postprandial values are high, with dose titration by a trained team. Teach injection technique, storage, site rotation, meter use, recognition and treatment of hypoglycaemia, sick-day contact and safe disposal of sharps. Dose requirements can rise as pregnancy advances and fall rapidly after delivery; copying a static dose is unsafe. The NHM guideline includes metformin after 20 weeks for selected patients when medical nutrition therapy fails, with explicit contraindications and escalation to insulin when control remains inadequate. WHO 2025 supports pharmacotherapy selected through individualised assessment. Do not use other oral glucose-lowering medicines in pregnancy unless a specialist guideline specifically supports them. Review renal and hepatic status and interacting illness before metformin; explain gastrointestinal effects and that it crosses the placenta. Never prescribe a drug to compensate for starvation or omit adequate carbohydrates. Antenatal corticosteroids can temporarily worsen glucose and require an anticipatory monitoring plan. Beta-agonists and acute illness can also change requirements. Write concentrations and units clearly to prevent tenfold insulin errors, and never abbreviate units ambiguously. Postpartum prescriptions must be reconciled immediately: many women with GDM need no medication, while persistent hyperglycaemia needs formal classification and treatment. Breastfeeding compatibility, contraception and future preconception optimisation belong in the discharge prescription review.
When to Refer
Refer promptly to an obstetric-diabetes team when GDM is diagnosed early, glucose is markedly elevated, overt diabetes is possible, ketones are present, targets remain unmet, hypoglycaemia is recurrent, insulin is needed, comorbidity is significant or self-monitoring cannot be implemented safely. Urgent hospital assessment is required for vomiting with dehydration, abdominal pain, tachypnoea, altered sensorium, ketonaemia or severe hyperglycaemia because diabetic ketoacidosis can occur at lower glucose in pregnancy. Escalate obstetric care for hypertension or pre-eclampsia symptoms, growth abnormality, polyhydramnios, reduced fetal movement, threatened preterm birth or concern about fetal wellbeing. Dietitian and diabetes-educator referral should be culturally and economically appropriate, not a generic diet sheet. Consider mental-health support when diagnosis causes severe anxiety or disordered eating. Plan delivery at a facility appropriate for medicine use, fetal size and maternal disease, with neonatal glucose and feeding capability. After birth, refer persistent abnormal glucose to diabetes services; a normal postpartum test still requires primary-care prevention and periodic surveillance. A referral should include the diagnostic protocol and value, gestation, glucose profile, medicines and doses, maternal weight and blood pressure, fetal growth, complications and practical barriers. Do not transfer responsibility without confirming who will titrate treatment and who will retrieve postpartum results.
Red Flags
Emergency metabolic red flags include persistent vomiting, inability to drink, dehydration, abdominal pain, deep or rapid breathing, fruity breath, confusion, drowsiness, positive ketones or severe hyperglycaemia. Pregnancy can develop ketoacidosis quickly and sometimes at glucose values lower than expected outside pregnancy. Treat this as an obstetric and medical emergency. Severe or recurrent hypoglycaemia, loss of consciousness or inability to self-treat also requires urgent help; family members should know the response plan. Obstetric red flags remain independent of glucose: severe headache, visual symptoms, epigastric pain, convulsion, vaginal bleeding, leaking fluid, painful contractions, fever, reduced fetal movement or acute breathlessness needs immediate assessment. Rapid fundal growth or polyhydramnios warrants expedited review but is not usually an emergency in isolation. Repeated values above the agreed threshold, a fasting pattern that is worsening, or a meter log inconsistent with laboratory results should trigger prompt treatment review rather than waiting for the next routine visit. In labour or when fasting for a procedure, use a written insulin and glucose-monitoring protocol to prevent both hyperglycaemia and hypoglycaemia. Postpartum excessive thirst, polyuria, weight loss or an abnormal test must not be dismissed because GDM 'ends at delivery'. Safety-net advice should give exact contact routes and explain that reduced fetal movement is assessed on its own merits, not reassured by a recent normal glucose reading.
Indian Clinical Context
India's NHM pathway uses universal rather than risk-factor-only testing and a feasible non-fasting 75 g oral glucose method. This responds to high background diabetes risk and the practical loss caused by requiring pregnant women to return fasting. The result must still be analytically sound: use the full measured glucose load, correct two-hour timing and venous plasma testing; document vomiting or incomplete ingestion. The national guideline places testing at first contact and again at 24-28 weeks after a negative early result. Public services need a reliable supply of glucose, labelled timed samples, referral access, insulin cold-chain support, meters and strips, and follow-up through ANC and community teams. Dietary advice should use affordable local foods and household meal patterns; banning rice or fruit wholesale is poor care. Metformin access does not remove the need for contraindication review, monitoring and explanation. The national diagnostic threshold may differ from WHO/IADPSG fasting multi-sample criteria used in private or international settings. Both are legitimate within their defined pathway, but mixing values creates errors; record the method. Link postpartum testing to NCD clinics or primary care because attendance is often lost after neonatal visits take priority. The NMC curriculum should train graduates to perform the glucose test, interpret the correct protocol, counsel without stigma, recognise ketoacidosis and hypoglycaemia, and coordinate obstetric, medical and neonatal care.
NMC Competency Mapping
GDM integrates NMC competencies in obstetrics, physiology, biochemistry, medicine, pharmacology, paediatrics, nutrition and communication. The learner should explain pregnancy insulin resistance, distinguish screening from diagnosis, prepare and supervise the national 75 g test, document timing and sample type, interpret the 2-hour threshold and recognise possible overt diabetes. Clinical assessment includes BMI and blood pressure, prior obstetric and diabetes history, fundal-height trajectory, fetal movement and features of pre-eclampsia or ketoacidosis. Management knowledge covers medical nutrition therapy, safe activity, glucose self-monitoring, insulin principles, selected metformin use, fetal surveillance, delivery planning, neonatal hypoglycaemia prevention and postpartum testing. Skills include teaching meter and injection technique under supervision, identifying hypoglycaemia, giving a structured referral handover and counselling about future type 2 diabetes. Professional practice avoids blame, respects food culture and cost, and clearly names the diagnostic protocol. Learners must recognise scope: insulin titration, delivery timing and complex diabetes care require supervision and local policy. Suitable assessments include an OSCE explaining a positive DIPSI-style test, a glucose-log interpretation station, an emergency scenario with ketones, and postpartum discharge planning. Exact OG, medicine and paediatric competency codes should be taken from the institution's NMC 2024 map rather than fabricated. Competence is demonstrated by safe decisions and continuity, not recall of a single threshold.
Key Exam Pearls for NEET PG
GDM is hyperglycaemia first recognised in pregnancy below overt-diabetes criteria. Indian NHM guidance endorses universal 75 g oral glucose testing irrespective of the last meal; 2-hour venous plasma glucose at least 140 mg/dL diagnoses GDM in that pathway. Test at the first ANC contact and repeat at 24-28 weeks if negative. State the protocol in an exam answer because fasting WHO/IADPSG criteria use different time points and thresholds. Risk factors do not replace screening. Glycosuria is not diagnostic and HbA1c does not replace the OGTT. First management is medical nutrition therapy and safe exercise with glucose monitoring. Add pharmacotherapy when targets remain unmet; insulin is adaptable and widely established, while India's guideline allows selected metformin use after assessment. Placental hormones increase insulin resistance as pregnancy advances, so dose requirements often rise; they may fall rapidly postpartum. Complications include macrosomia, shoulder dystocia, pre-eclampsia, polyhydramnios, operative delivery and neonatal hypoglycaemia. Maternal hyperglycaemia causes fetal hyperinsulinaemia; after placental glucose stops, neonatal insulin can remain high. GDM alone does not mandate caesarean birth. Ketoacidosis is possible at comparatively modest glucose in pregnancy. Postpartum glucose testing is mandatory because persistent diabetes may be uncovered and lifetime type 2 diabetes risk is elevated. Document GDM for future preconception care and screen in later pregnancies.
Frequently Asked Questions
Does gestational diabetes screening require fasting in India?
The national NHM pathway uses 75 g oral glucose irrespective of the last meal, with venous plasma glucose measured two hours later; at least 140 mg/dL diagnoses GDM in that protocol. Other services may use a fasting multi-sample OGTT with different thresholds. The clinician must document and interpret the protocol actually used rather than combine values from different systems.
Can gestational diabetes be managed without insulin?
Many patients reach targets with individualised nutrition, safe activity and monitoring. Medication is needed when glucose remains above target or is substantially elevated. Insulin is commonly used; the Indian guideline also permits metformin for selected patients after assessment. The choice depends on glucose pattern, gestation, contraindications, preferences and access, and must include a monitoring and escalation plan.
Does gestational diabetes automatically mean a caesarean birth?
No. Mode and timing of birth depend on glucose control, fetal growth, maternal complications, obstetric history, cervical and labour factors, and local protocol. GDM increases the chance of intervention but is not itself an automatic indication for caesarean delivery. Delivery planning should be individualised and include neonatal readiness for feeding and glucose observation when indicated.
Why is glucose testing needed again after delivery?
Pregnancy-related insulin resistance often resolves, but some patients had previously unrecognised diabetes and many remain at high lifetime risk of type 2 diabetes. Postpartum testing classifies current glucose status, while continuing periodic surveillance supports prevention and early treatment. A normal test is reassuring only for that time; the GDM history should remain permanently visible in medical records.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic